Paraplegia and Tetraplegia

5

Review clinical trials related to Paraplegia and Tetraplegia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)

The purpose of this research study is to measure the tolerability and preliminary efficacy of a drug, galantamine, to treat metabolic syndrome (MetS) by reducing circulating inflammation in people with spinal cord injury (SCI). Galantamine is FDA-approved for the treatment of Alzheimer's disease. Here, the drug is considered experimental for the purposes of this study.

Participants needed: 60
Trial details
Phase: Phase 2, Phase 3Age: 21-75Biological sex: AllType: InterventionalSponsor: Northwell HealthUpdated: Jun 4, 2026Locations: 3
Eligibility criteria

Adults aged 21-75 years (male or female) [+11]

Diagnosis of neurological injury or condition other than SCI [+12]

Status: Recruiting

Self-balancing Personal Exoskeleton for SCI (WIP)

This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).

Participants needed: 10
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: WandercraftUpdated: Apr 17, 2026Locations: 1
Eligibility criteria

Any gender, age 18 years or older [+5]

Diagnosis of neurological injury other than SCI; [+26]

Status: Recruiting

Self-balancing Personal Exoskeleton for SCI (WINY)

This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).

Participants needed: 12
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: WandercraftUpdated: Feb 2, 2026Locations: 1
Eligibility criteria

Any gender, age 18 years or older; [+5]

Diagnosis of neurological injury other than SCI; [+29]

Status: Recruiting

Self-balancing Personal Exoskeleton for SCI (Site 2)

This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).

Participants needed: 24
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: WandercraftUpdated: Feb 2, 2026Locations: 1
Eligibility criteria

Any gender, age 18 years or older; [+5]

Diagnosis of neurological injury other than SCI; [+30]

Status: Recruiting

Self-balancing Personal Exoskeleton for SCI

This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).

Participants needed: 24
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: WandercraftUpdated: Feb 2, 2026Locations: 1
Eligibility criteria

Any gender, age 18 years or older; [+5]

Diagnosis of neurological injury other than SCI; [+29]